Fulminant Hepatitis

Fulminant Hepatitis

People who have fulminant hepatitis typically develop the symptoms seen in viral hepatitis and then rapidly (within hours, days, or occasionally weeks) develop severe, often life-threatening liver failure.

Symptoms of severe liver failure include confusion, extreme irritability, altered consciousness (usually leading to unconsciousness or coma), blood-clotting defects, and buildup of fluid in the abdominal cavity, arms, and legs.

  • The only known way to prevent fulminant viral hepatitis is to prevent viral hepatitis infection.
  • No medication can reverse fulminant hepatitis. People who have fulminant hepatitis need to be hospitalized in an intensive care unit so they can be cared for until their condition becomes more stable. For some people, a liver transplant is the only lifesaving option. People younger than age 40 who have fulminant hepatitis are more likely to recover than older adults or people who have chronic liver disease.
  • Depending on the cause of the fulminant hepatitis, about 40% to 70% of people recover without receiving major treatment.1

Citations

  1. Bell BP, et al. (2004). Hepatitis A virus. In RD Feigin et al., eds., Textbook of Pediatric Infectious Diseases, 5th ed., vol. 2, pp. 2069–2086. Philadelphia: Saunders.
By Healthwise Staff
Primary Medical Reviewer Kathleen Romito, MD - Family Medicine
Specialist Medical Reviewer Adam Husney, MD - Family Medicine
Last Revised August 30, 2010

Last Revised: August 30, 2010

Author: Healthwise Staff

Medical Review: Kathleen Romito, MD - Family Medicine & Adam Husney, MD - Family Medicine

This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.

To learn more visit Healthwise.org

© 1995-2011 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.

Latest Hepatitis News
Impressive Vertex hepatitis C drug data unveiled

November 1, 2008 - A closely watched hepatitis C treatment being developed by Vertex Pharmaceuticals Inc showed an impressive ability to knock out the virus in patients who failed other treatments and those not previously treated for the serious liver disease, data from mid-stage studies show.

U.S. hepatitis A vaccine rates vary widely

January 25, 2012 — NEW YORK (Reuters Health) - Although about 85 percent of kids in two U.S. states have had a complete set of hepatitis A vaccines, overall just three in 10 have had both shots, according to a new survey from the Centers for Disease Control and Prevention (CDC).

Device makers urge coverage of weight-loss surgery

January 25, 2012 — CHICAGO (Reuters) - Device manufacturers are pushing the U.S. government and health insurers to cover weight-loss surgery, an effort that could give millions more obese Americans access to the treatments.

Arsenic cancer risk still high decades later

January 24, 2012 — NEW YORK (Reuters Health) - People exposed to very high levels of arsenic in Chilean drinking water back in the 1950s and 60s are still showing a higher-than-normal risk of bladder cancer -- years after the arsenic problem was brought under control, a new study shows.

Select news items provided by Reuters Health